Mirtazapine--a new antidepressant
Medical Letter on Drugs and Therapeutics 38(990): 113-114
1996
ISSN/ISBN: 0025-732X PMID: 8988154 Document Number: 458604
Document emailed within 1 workday
Related Documents
Hartmann, P.M. 1999: Mirtazapine: a newer antidepressant American Family Physician 59(1): 159-161McCombs, J.S.; Nichol, M.B.; Stimmel, G.L.; Sclar, D.A.; Beasley, C.M.; Gross, L.S. 1990: The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population Journal of Clinical Psychiatry 51 Suppl: 60-69; Discussion: 70-71
Meyboom, R.H.; Edwards, I.R.; Egberts, A.C. 1999: Mirtazapine and the granulocytes--so far so good New Zealand Medical Journal 112(1084): 104
Quitkin, F.M.; Taylor, B.P.; Kremer, C. 2001: Does mirtazapine have a more rapid onset than SSRIs? Journal of Clinical Psychiatry 62(5): 358-361
2003: Olanzapine and mirtazapine for multiple palliation Journal of Supportive Oncology 1(1): 64
Perez, D.G.; Loprinzi, C.L.; Barton, D.L.; Pockaj, B.A.; Sloan, J.; Novotny, P.J.; Christensen, B.J. 2004: Pilot evaluation of mirtazapine for the treatment of hot flashes Journal of Supportive Oncology 2(1): 50-56
Burrows, G.D.; Kremer, C.M. 1997: Mirtazapine: clinical advantages in the treatment of depression Journal of Clinical Psychopharmacology 17(Suppl): 34s-39s
Knud Larsen, J. 2012: Mirtazapine versus other antidepressive agents for depression Ugeskrift for Laeger 174(46): 2864-2866
Zueco Pérez, P.L. 2002: Mirtazapine in the treatment of cocaine-dependence in patients with methadone Actas Espanolas de Psiquiatria 30(6): 337-342
Dolder, C.R.; Nelson, M.H.; Iler, C.A. 2012: The effects of mirtazapine on sleep in patients with major depressive disorder Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 24(3): 215-224
Wang, X.-Q.; Pan, X.-J.; Lin, G.-Y.; Xiang, Z.; Wang, X.-B.; Wu, J.-Z.; Lin, D. 2009: Simultaneous determination of clozapine, olanzapine and mirtazapine in human plasma by LC-MS/MS Fa Yi Xue Za Zhi 25(2): 123-126
Niedermaier, N.; Bohrer, E.; Schulte, K.; Schlattmann, P.; Heuser, I. 2004: Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke Journal of Clinical Psychiatry 65(12): 1619-1623
Prospero-Garcia, K.A.; Torres-Ruiz, A.; Ramirez-Bermudez, J.; Velazquez-Moctezuma, J.; Arana-Lechuga, Y.; Teran-Perez, G. 2006: Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial Journal of Clinical Psychiatry 67(11): 1820
Kadhe, N.G.; Chillar, A.J.; Deshmukh, Y.A. 2003: Reboxetine: a novel antidepressant Journal of Postgraduate Medicine 49(4): 373-375
Jensen, D.; Joyce, P.R. 1989: Antidepressant mythology New Zealand Medical Journal 102(869): 288-290
Lippmann, S. 1982: Antidepressant pharmacotherapy American Family Physician 25(6): 145-153
Popli, A.P.; Tanquary, J. 1994: Antidepressant-associated seizures Journal of Clinical Psychiatry 55(6): 267
Auster, R. 1993: Sertraline: a new antidepressant American Family Physician 48(2): 311-314
Jefferson, J.W. 1995: Just what is a heterocyclic antidepressant? Journal of Clinical Psychiatry 56(9): 433
Calesnick, B. 1980: Tricyclic antidepressant toxicity American Family Physician 21(6): 104-106